Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Companyâs XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Employees

3,660

Sector

Advanced Medical Equipment & Technology

Calendar

2025-02-05 - Q4 2024 Earnings Release

More about the company

Quotes

Date	Price	Change	Volume
25-01-22	42.62 $	-0.68%	282,962
25-01-21	42.91 $	+0.80%	390,289
25-01-17	42.57 $	+1.02%	255,724
25-01-16	42.14 $	-2.30%	325,112
25-01-15	43.13 $	+1.91%	271,904

Delayed Quote Nasdaq, January 22, 2025 at 04:00 pm

More quotes

Income Statement and Estimates

income-statement-evolution-chart OMNICELL-INC

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

42.62USD

Average target price

54.14USD

Spread / Average Target

+27.04%

Consensus

Profit revisions

Estimate revisions

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 16:00:00 2025-01-22 EST			5-day change	1st Jan Change
42.62 ^USD	-0.68%		-1.18%	-4.27%

Capitalization	1.97B 1.9B 1.79B 1.6B 2.84B 171B 3.15B 21.75B 8.01B 70.38B 7.41B 7.25B 309B	P/E ratio 2024 *	232x	P/E ratio 2025 *	76.3x
Enterprise value	1.98B 1.9B 1.79B 1.6B 2.84B 171B 3.15B 21.77B 8.02B 70.46B 7.41B 7.26B 309B	EV / Sales 2024 *	1.79x	EV / Sales 2025 *	1.63x
Free-Float	80.46%	Yield 2024 *	-	Yield 2025 *	-

Omnicell Seeks Opportunities in AI	01-15	CI
Omnicell, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 01:30 PM	01-15
BofA Securities Adjusts Price Target on Omnicell to $46 From $54	01-06	MT
Omnicell Insider Sold Shares Worth $567,638, According to a Recent SEC Filing	12-12	MT
Omnicell, Inc. Announces OmniSphere	12-09	CI
LSPedia and Omnicell Collaborate in an Effect to Advance Pharmacy Supply Chain Compliance and Innovation for Healthcare and Health Systems	12-04	CI
Omnicell Prices $150 Million Convertible Senior Notes Offering	11-20	MT
Omnicell, Inc. Enters into A First Amendment to Second Amended and Restated Credit Agreement with the Lender	11-18	CI
Omnicell Launching $150 Million Private Placement of Convertible Notes	11-18	MT
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on August 5, 2016.	11-08	CI
BofA Securities Downgrades Omnicell to Neutral From Buy, Adjusts Price Target to $57 From $44	24-10-31	MT
Top Midday Gainers	24-10-30	MT
Omnicell's Q3 Adjusted Earnings, Revenue Increase; Raises 2024 Guidance	24-10-30	MT

BofA Securities Adjusts Price Target on Omnicell to $46 From $54	01-06	MT
BofA Securities Downgrades Omnicell to Neutral From Buy, Adjusts Price Target to $57 From $44	24-10-31	MT
Barclays Upgrades Omnicell to Equalweight From Underweight, Adjusts Price Target to $39 From $26	24-08-02	MT
Wells Fargo Adjusts Price Target on Omnicell to $26 From $28, Maintains Equal-Weight Rating	24-02-09	MT
Piper Sandler Upgrades Omnicell to Overweight From Neutral, Cuts Price Target to $39 From $70	23-11-03	MT

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025	01-13	BU
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference	01-08	BU
Omnicell Announces OmniSphere	12-09	BU
Omnicell : Announces Pricing of $150 Million Convertible Senior Notes Offering Form 8 K	11-25	PU
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference	11-25	AQ

Omnicell, Inc. Stock

Equities

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Valuation: Omnicell, Inc.

Chart: Omnicell, Inc.

Latest news: Omnicell, Inc.

Last Transcript: Omnicell, Inc.

Analysts' recommendations: Omnicell, Inc.

Press Releases: Omnicell, Inc.

News in other languages: Omnicell, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Omnicell, Inc.

ETFs: Omnicell, Inc.

Medical Software & Technology Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

USA-Les valeurs à suivre à Wall Street (actualisé)	22-07-15
Omnicell : kooperiert im Rahmen der Ausweitung der Omnicell-Systeme im gesamten South East London NHS Integrated Care System mit dem Guy's and St Thomas' NHS Foundation Trust, London, bei der Entwicklung eines europäischen, technologiegestützten...	21-01-05
Omnicell : s’associe au Guy’s and St Thomas’ NHS Foundation Trust de Londres pour le développement d’un centre européen de veille technologique, dans le cadre de l’expansion des systèmes d’Omnicell dans l’ensemble du South East London NHS Integrated...	21-01-05
Quels ETF choisir pour investir dans les valeurs moyennes ?	21-01-04
USA-Les valeurs à suivre à Wall Street (actualisé)	20-12-09

1 day	-0.68%
1 week	-1.18%
Current month	-4.27%
1 month	-5.25%
3 months	+3.70%
6 months	+52.00%
Current year	-4.27%

Director	Title	Age	Since
Randall Lipps CEO	Chief Executive Officer	67	2002-09-30
Nchacha Etta DFI	Director of Finance/CFO	-	2023-05-31
Prasad Srinivasamurthy CTO	Chief Tech/Sci/R&D Officer	-	-

Manager	Title	Age	Since
Randall Lipps CHM	Chairman	67	1992-08-31
Mark Parrish BRD	Director/Board Member	69	2012-12-31
Joanne Bauer BRD	Director/Board Member	69	2013-12-31

Name	Weight	AuM	1st Jan change	Investor Rating
GLOBAL X ROBO GLOBAL ROBOTICS & AUTOMATION ETF - AUD	1.46%	141 M€	+5.73%
PING AN NASDAQ AI AND ROBOTICS ETF - DISTRIBUTING - USD	0.38%	0 M€	+10.81%	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
OMNICELL, INC.	-0.68%	-1.18%	+25.61%	-71.21%	1.99B
VEEVA SYSTEMS INC.	+2.70%	+8.19%	+9.40%	+3.15%	36.21B
PRO MEDICUS LIMITED	-0.36%	+5.70%	+164.04%	+494.19%	17.22B
SECTRA AB	-1.18%	-2.46%	+33.36%	+63.03%	4.39B
VERADIGM INC.	-5.33%	-8.49%	-10.22%	-50.29%	1.53B
LUNIT INC.	-0.30%	+4.26%	-4.76%	-	1.34B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+4.37%	+6.82%	-	-	1.3B
EVOLENT HEALTH, INC.	-1.67%	+0.30%	-67.67%	-54.83%	1.17B
B-SOFT CO.,LTD.	-1.65%	-2.79%	-13.10%	-56.95%	903M
SURGICAL SCIENCE SWEDEN AB	-1.70%	-2.04%	-0.23%	-17.42%	816M
Average	-0.59%	+1.08%	+15.16%	+38.71%	6.69B
Weighted average by Cap.	+1.14%	+3.98%	+49.57%	+133.19%

	2024 *	2025 *
Net sales	1.11B 1.06B 1B 897M 1.59B 95.56B 1.76B 12.18B 4.48B 39.41B 4.15B 4.06B 173B	1.16B 1.11B 1.05B 940M 1.66B 100B 1.85B 12.75B 4.7B 41.26B 4.34B 4.25B 181B
Net income	8.47M 8.13M 7.69M 6.88M 12.18M 732M 13.52M 93.33M 34.38M 302M 31.78M 31.12M 1.33B	26.63M 25.57M 24.17M 21.62M 38.29M 2.3B 42.49M 293M 108M 949M 99.9M 97.82M 4.17B
Net Debt	2.17M 2.09M 1.97M 1.76M 3.13M 188M 3.47M 23.94M 8.82M 77.5M 8.15M 7.98M 340M	-84.86M -81.48M -77.01M -68.9M -122M -7.34B -135M -935M -344M -3.03B -318M -312M -13.29B